Brochure
25 Sep 2020
Helping Customers Evaluate their Nitrosamine Risk Level
PDF 158 kB
Nitrosamine Risk Assessments for pharmaceutical excipients are now available for instant download in RegXcellence™️. These statements provide increased transparency to our customers and help to better understand the potential for Nitrosamine formation and presence.
Content provided by our supplier
BASF SE
-
Country/Region:Germany
-
On CPHI since:2015
-
Employees:5000+
Company types
.jpg)
Other Content from BASF SE (3)
-
Brochure BASF Pharma Solutions Product Overview
With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is the leading supplier of select APIs such as ibuprofen and omega-3. -
Brochure Supporting Your COVID-19 Therapy Development
Healthcare and pharmaceutical development are at the forefront of the COVID-19 crisis as we know it. The BASF Pharma Solutions team is actively engaged in supporting the COVID-19 therapy developments of our customers in a comprehensive way. -
Video Streamline Compliance with RegXcellence™️ from BASF Pharma Solutions
RegXcellence®️ is available online 24/7 to help customers easily navigate the complex quality and regulatory space. Customers can access a compliance document library, connect with global and regional experts, stay up to date on all documentation and requests, and more.